Key steps in pursuing a strategy of active surveillance for very low-risk prostate cancer

November 11, 2020
Urology Times staff

Christopher P. Evans, MD, discusses his active surveillance protocol with J. Brantley Thrasher, MD.

In this interview, Christopher P. Evans, MD, discusses the use of active surveillance in men with low-risk prostate cancer. Evans is professor and chair of the Department of Urologic Surgery at the University of California, Davis, School of Medicine. He was interviewed by Urology Times® Editorial Consultant J. Brantley Thrasher, MD, executive director of the American Board of Urology, Charlottesville, Virginia.

More videos:

App facilitates assessment of urologic chronic pelvic pain syndrome

Testosterone therapy does not appear to worsen outcomes in men with COVID-19

HIFU for prostate cancer: How it works, criteria for treatment, and contraindications

Related Content:

Prostate Cancer | UTv